CTMI Cti Molecular Imaging - Common Stock (MM)

CTI Molecular Imaging Announces the Release of PET.CONNECT(TM) CTI Expands its Product Line KNOXVILLE, Tenn., Nov. 29 /PRNewswire-FirstCall/ -- CTI Molecular Imaging, Inc. (NASDAQ:CTMI), a leading provider of positron emission tomography (PET) equipment, molecular biomarkers and services, today announced that its subsidiary CTI PETNET will release and distribute PET.CONNECT, an innovative application that includes a wide range of IT products, educational programs and service offerings, designed to provide all the capabilities necessary to run a successful PET imaging practice. PET.CONNECT consists of innovative applications for Image Analysis, PET Education and Marketing, and Practice Management. The Image Analysis software in PET.CONNECT, created by CTI Mirada Solutions, includes a suite of diagnostic applications spanning oncology, neurology, and cardiology. The PET Education and Marketing programs are designed to provide the user with all the tools necessary to educate their community on the advantages of PET and PET/CT. The integrated Practice Management applications provide a turnkey solution to streamlining the daily operations of a PET center. By combining reliable dose delivery, image analysis software, PET education and marketing with practice management tools, CTI PETNET offers PET providers the most powerful range of services available to increase productivity, improve diagnostic accuracy and successfully grow their practice. "Building a successful PET practice requires highly specialized resources and expertise not found with other modalities. With the creation of PET.CONNECT, we have made it easier for our customers to succeed by integrating these requirements into one cohesive program," said Joe Sardano, Senior Vice President of Sales and Marketing. "In addition to CTI Mirada products like the MiraView(TM) workstation for image review and analysis, and Fusion7D(TM) with rigid and non-rigid image fusion capabilities, PET.CONNECT includes exciting new products like Novisis(TM), an invaluable tool in monitoring response to therapy or disease progression over time," said Christian P. Behrenbruch, President of CTI Mirada Solutions. Through the creation of PET.CONNECT, CTI Molecular Imaging and its subsidiaries are providing the tools and services necessary to make a PET imaging practice successful. About CTI Molecular Imaging: CTI Molecular Imaging, Inc. is a leading supplier of products and services for positron emission tomography (PET), a diagnostic imaging technology used in the detection and treatment of cancer, neurological disorders, and cardiac disease. Additional information is available at: http://www.ctimi.com/ . Certain matters discussed in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements, which may be identified by words such as "assume," "expect," "anticipate," "intend," "estimate" or similar expressions, include statements regarding the anticipated financial impact and operational improvements resulting from the new distribution arrangement with Siemens and any other statements that necessarily depend on future events. Forward-looking statements involve a number of risks and uncertainties and there can be no assurance that any forward-looking statements will prove to be accurate. Various factors could cause actual results to differ materially from those anticipated in the forward-looking statements. CTI undertakes no obligation to update or revise any forward-looking statements. Further information regarding risks, uncertainties and other factors that could adversely affect CTI or cause actual results to differ materially from those anticipated in forward-looking statements are included in CTI's Annual Report on Form 10-K for the fiscal year ended September 30, 2003 and Quarterly Report on Form 10-Q for the quarter ended June 30, 2004. Website: http://www.ctimi.com DATASOURCE: CTI Molecular Imaging, Inc. CONTACT: Lisa Baird of CTI Molecular Imaging, Inc., +1-865-218-2000

Copyright